Quick Answer
Korro Bio, Inc. reported Diluted EPS of $12.48 per share (loss) for fiscal year 2025.
Korro Bio, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$12.48 | -33.2% |
| 2024 | -$9.37 | +82.3% |
| 2023 | -$53.08 | +76.7% |
| 2022 | -$227.42 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.92 | +15.0% | +29.9% |
| June 30, 2025 | -$2.74 | -12.8% | -10.0% |
| March 31, 2025 | -$2.49 | -2.0% | -10.2% |
| September 30, 2024 | -$2.26 | +96.5% | +7.0% |
| June 30, 2024 | -$2.43 | +96.2% | +0.4% |
| March 31, 2024 | -$2.44 | +96.6% | +96.3% |
| September 30, 2023 | -$65.08 | -11732.7% | -2.0% |
| June 30, 2023 | -$63.83 | — | +11.6% |
- Korro Bio, Inc. showed a decrease of -33.2% in Diluted EPS compared to the prior fiscal year.
- Over the 2022–2025 period, Korro Bio, Inc.’s diluted eps has grown by 94.5% (from $227.42 per share (loss) to $12.48 per share (loss)).
- The most recent figure is from Korro Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: